The establishment in Kabul, Afghanistan, is proving to be a key factor in the worldwide supply market for Abacavir Sulphate API. This local manufacturing capability represents a substantial step beyond for the Afghan pharmaceutical industry and offers a special opportunity to mitigate dependence